We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.72%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$16.2B
AUM Growth
+$1.16B
(+7.7%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
13.75%
Holding
668
New
158
Increased
115
Reduced
144
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$255M |
| 2 |
Broadcom
AVGO
|
+$180M |
| 3 |
AstraZeneca
AZN
|
+$147M |
| 4 |
Intuitive Surgical
ISRG
|
+$142M |
| 5 |
TE Connectivity
TEL
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$441M |
| 2 |
AerCap
AER
|
+$184M |
| 3 |
Western Digital
WDC
|
+$157M |
| 4 |
Akamai
AKAM
|
+$127M |
| 5 |
EPAM Systems
EPAM
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.67% |
| 2 | Consumer Discretionary | 14.19% |
| 3 | Industrials | 13.31% |
| 4 | Healthcare | 12.83% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cummins
CMI
$87.4B
| $577K | ﹤0.01% |
+1,957
| New | +$504K |
|
427
Banc of California
BANC
$3B
| $562K | ﹤0.01% |
+36,959
| New | +$514K |
|
428
Welltower
WELL
$169B
| $541K | ﹤0.01% |
5,790
-50,415
| -90% | -$4.56M |
|
429
Marvell Technology
MRVL
$187B
| $531K | ﹤0.01% |
+7,486
| New | +$513K |
|
430
IN8bio
INAB
$9.61M
| $526K | ﹤0.01% |
14,867
-12,455
| -46% | -$470K |
|
|
VBIV
431
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $471K | ﹤0.01% |
782,000
| – | – |
|
|
OTLY
432
Oatly Group
OTLY
$419M
| $418K | ﹤0.01% |
+18,484
| New | +$415K |
|
433
Applovin
APP
$113B
| $417K | ﹤0.01% |
+6,029
| New | +$319K |
|
|
VBIV
434
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $377K | ﹤0.01% |
626,436
| – | – |
|
435
Hyperfine
HYPR
$101M
| $375K | ﹤0.01% |
375,000
| – | – |
|
436
Tonix Pharmaceuticals
TNXP
$201M
| $372K | ﹤0.01% |
625
-220
| -26% | -$237K |
|
437
AN2 Therapeutics
ANTX
$213M
| $325K | ﹤0.01% |
100,000
+50,000
| +100% | +$544K |
|
438
Surrozen
SRZN
$295M
| $320K | ﹤0.01% |
20,376
| – | – |
|
439
CalciMedica
CALC
$10.4M
| $312K | ﹤0.01% |
+75,082
| New | +$343K |
|
440
Owens Corning
OC
$12.2B
| $282K | ﹤0.01% |
+1,690
| New | +$258K |
|
441
Clene
CLNN
$65.9M
| $202K | ﹤0.01% |
23,707
-60,638
| -72% | -$524K |
|
|
AFMD
442
DELISTED
Affimed
AFMD
| $186K | ﹤0.01% |
35,000
| – | – |
|
443
Alto Neuroscience
ANRO
$1.1B
| $154K | ﹤0.01% |
+10,000
| New | +$157K |
|
|
AXDX
444
DELISTED
Accelerate Diagnostics
AXDX
| $79.7K | ﹤0.01% |
+80,547
| New | +$127K |
|
445
CALL
Abeona Therapeutics
ABEO
$425M
| – | – |
-70,000
| Closed | -$351K |
|
|
ABX
446
CALL
Abacus Global Management
ABX
$913M
| – | – |
-140,219
| Closed | -$1.35M |
|
|
ACB
447
CALL
Aurora Cannabis
ACB
$179M
| – | – |
-94,401
| Closed | -$450K |
|
448
CALL
Advantage Solutions
ADV
$383M
| – | – |
-19,547
| Closed | -$1.77M |
|
449
CALL
AEON Biopharma
AEON
$13.6M
| – | – |
-1,111
| Closed | -$576K |
|
450
Atlas Energy Solutions
AESI
$1.47B
| – | – |
-144,612
| Closed | -$2.49M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2024 Portfolio in Review
As of Q1 2024, Alyeska Investment Group held 668 positions worth $16.2B, up 7.7% from $15.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group's Q1 2024 filing shows 158 new, 115 increased, 144 reduced and 223 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,783,151 shares worth $269M. The largest sale was Meta Platforms (Facebook), an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q1 2024 buy was Alphabet (Google) Class A: 1,783,151 shares worth $269M.
- Alyeska Investment Group added most to AstraZeneca in Q1 2024, an estimated $147M increase.
- Alyeska Investment Group's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $441M.
- Alyeska Investment Group fully exited Akamai in Q1 2024, selling an estimated $127M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $16.2B portfolio in Q1 2024.
- Alyeska Investment Group opened 158 new positions and closed 223 in Q1 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $16.2B.
Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.